17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydroxyprogesterone caproate.
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Acarbose.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Acarbose.
Advertisement
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Acarbose.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Acarbose.
Anhydrous Tacrolimus
The therapeutic efficacy of Acarbose can be decreased when used in combination with Tacrolimus.
Advertisement
Aripiprazole
The therapeutic efficacy of Acarbose can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Articaine.
Advertisement
Asenapine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Acarbose.
Atazanavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Atazanavir.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Acarbose.
Bendroflumethiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Betamethasone.
Brexpiprazole
The therapeutic efficacy of Acarbose can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Bumetanide.
Buserelin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Buserelin.
Ceritinib
The therapeutic efficacy of Acarbose can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Acarbose may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Chlorthalidone.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Acarbose.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Acarbose.
Citalopram
Citalopram may increase the hypoglycemic activities of Acarbose.
Clozapine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Acarbose can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Acarbose can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Acarbose can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Darunavir.
Desogestrel
The therapeutic efficacy of Acarbose can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Acarbose.
Dexamethasone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Diazoxide.
Dienogest
The therapeutic efficacy of Acarbose can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Acarbose.
Digoxin
The serum concentration of Digoxin can be decreased when it is combined with Acarbose.
Disopyramide
Acarbose may increase the hypoglycemic activities of Disopyramide.
Drospirenone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Drospirenone.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Acarbose.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Acarbose.
Epinephrine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Epinephrine.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Acarbose.
Estradiol
The therapeutic efficacy of Acarbose can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Acarbose can be decreased when used in combination with Etacrynic acid.
Ethinyl Estradiol
The therapeutic efficacy of Acarbose can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Acarbose can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Acarbose can be decreased when used in combination with Everolimus.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Acarbose.
Fludrocortisone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Fludrocortisone.
Flumequine
Flumequine may increase the hypoglycemic activities of Acarbose.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Acarbose.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Acarbose.
Fluvoxamine
Fluvoxamine may increase the hypoglycemic activities of Acarbose.
Fosamprenavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Fosamprenavir.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Acarbose.
Furosemide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Acarbose.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Acarbose.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Acarbose.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Acarbose.
Gliclazide
Acarbose may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Acarbose may increase the hypoglycemic activities of Glimepiride.
Glipizide
Acarbose may increase the hypoglycemic activities of Glipizide.
Glyburide
Acarbose may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Acarbose.
Histrelin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Acarbose can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Acarbose can be decreased when used in combination with Indinavir.
Insulin Detemir
Acarbose may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Acarbose may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Acarbose may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Acarbose may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Acarbose may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Acarbose may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Acarbose may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Acarbose may increase the hypoglycemic activities of Insulin Lispro.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Acarbose.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Acarbose.
Lanreotide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Lanreotide.
Leuprolide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Leuprolide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Acarbose.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Acarbose.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Acarbose.
Levonorgestrel
The therapeutic efficacy of Acarbose can be decreased when used in combination with Levonorgestrel.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Acarbose.
Lopinavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Lurasidone.
Mecasermin
Acarbose may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Acarbose may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Acarbose can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Acarbose.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Acarbose.
Mestranol
The therapeutic efficacy of Acarbose can be decreased when used in combination with Mestranol.
Methotrimeprazine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Acarbose.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Acarbose.
Methylprednisolone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Acarbose.
Metolazone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Metolazone.
Mifepristone
Acarbose may increase the hypoglycemic activities of Mifepristone.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Acarbose.
Minaprine
Minaprine may increase the hypoglycemic activities of Acarbose.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Acarbose.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Acarbose.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Acarbose.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Acarbose.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Acarbose.
Nateglinide
Acarbose may increase the hypoglycemic activities of Nateglinide.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Acarbose.
Nelfinavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Nelfinavir.
Neomycin
The risk or severity of adverse effects can be increased when Neomycin is combined with Acarbose.
Niacin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Acarbose.
Nilotinib
The therapeutic efficacy of Acarbose can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Acarbose.
Norgestimate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Norgestimate.
Octreotide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Octreotide.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Acarbose.
Olanzapine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Acarbose.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Acarbose.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Acarbose.
Paliperidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Acarbose.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Acarbose.
Pasireotide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Acarbose.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Acarbose.
Pentamidine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Pentamidine.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Acarbose.
Piperazine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Polythiazide.
Prednisolone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Acarbose.
Procaine
Procaine may increase the hypoglycemic activities of Acarbose.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Acarbose.
Progesterone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Progesterone.
Quetiapine
The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Quinethazone.
Quinine
Acarbose may increase the hypoglycemic activities of Quinine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Acarbose.
Regular Insulin, Human
Acarbose may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Acarbose may increase the hypoglycemic activities of Repaglinide.
Risperidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Ritonavir.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Acarbose.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Acarbose.
Saquinavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Acarbose can be decreased when used in combination with Saquinavir.
Selegiline
Selegiline may increase the hypoglycemic activities of Acarbose.
Sertraline
Sertraline may increase the hypoglycemic activities of Acarbose.
Sirolimus
The therapeutic efficacy of Acarbose can be decreased when used in combination with Sirolimus.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Acarbose.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Acarbose.
Sulfadiazine
Acarbose may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Acarbose may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Acarbose may increase the hypoglycemic activities of Sulfisoxazole.
Sunitinib
Acarbose may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Acarbose can be decreased when used in combination with Tacrolimus.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Acarbose.
Temsirolimus
The therapeutic efficacy of Acarbose can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Acarbose.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Acarbose.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Acarbose.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Acarbose.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Acarbose.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Acarbose.
Tipranavir
The therapeutic efficacy of Acarbose can be decreased when used in combination with Tipranavir.
Tolazamide
Acarbose may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Acarbose may increase the hypoglycemic activities of Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Acarbose.
Torsemide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Acarbose.
Triamcinolone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Acarbose can be decreased when used in combination with Trichlormethiazide.
Triptorelin
The therapeutic efficacy of Acarbose can be decreased when used in combination with Triptorelin.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Acarbose.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Acarbose.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Acarbose.
Vorinostat
The therapeutic efficacy of Acarbose can be decreased when used in combination with Vorinostat.
Ziprasidone
The therapeutic efficacy of Acarbose can be decreased when used in combination with Ziprasidone.
